Amisulpride the 'atypical' atypical antipsychotic - Comparison to haloperidol, risperidone and clozapine
Sridhar Natesan, Greg E Reckless, Karren BL Barlow, Jose N Nobrega, Shitij Kapur
Schizophrenia Research | ELSEVIER | Published : 2008
Shitij Kapur has received grant support or has been/is a consultant/scientific advisor or on speaking engagements for AstraZeneca Bristol Meyers Squibb, Eli Lilly, EMD Darmstadt, Glaxo Smit Kline, Janssen (Johnson and Johnson), Neuromolecular Inc., Otsuka, Organon, Pfizer, Sanofi-Synthelabo, Servier, Solvay and Wyeth. Other authors have none to declare.